FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Kelly Scott A. 2. Issuer Name and Ticker or Trading Symbol CytoDyn Inc. [ CYDY ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chairman & CMO
(Last)         (First)         (Middle)
C/O CYTODYN INC., 1111 MAIN STREET, SUITE 660
3. Date of Earliest Transaction (MM/DD/YYYY)
5/1/2020
(Street)
VANCOUVER, WA 98660
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
5/5/2020 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  5/1/2020    M    7123  A $0.61  1325293  D   
Common Stock  5/1/2020    M    75000  A $0.57  1400293  D   
Common Stock  5/1/2020    M    97009  A $0.56  1497302  D   
Common Stock  5/1/2020    M    100000  A $0.49  1597302  D   
Common Stock  5/1/2020    M(1)    250000  A $0.565  1847302  D   
Common Stock  5/1/2020    M    66666  A $0.52  1913968  D   
Common Stock  5/1/2020    M    750000  A $0.385  2663968  D   
Common Stock  5/1/2020    M    93750  A $0.39  2757718  D   
Common Stock  5/1/2020    S    1200000  D $3.2604 (2) 1557718  D   
Common Stock  5/4/2020    M    8334  A $0.52  1566052  D   
Common Stock                 691208  I  By Spouse 
Common Stock                 23180  I  As Custodian for daughter (3)
Common Stock                 22980  I  By Custodian for daughter (3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Nonqualified Stock Option-right to buy  $0.61  5/1/2020    M     7123      5/31/2017  4/10/2027  Common Stock  7123  $0  0  D   
Nonqualified Stock Option-right to buy  $0.57  5/1/2020    M     75000      6/1/2018  6/1/2027  Common Stock  75000  $0  0  D   
Nonqualified Stock Option-right to buy  $0.56  5/1/2020    M     97009      2/7/2018  2/7/2028  Common Stock  97009  $0  0  D   
Nonqualified Stock Option-right to buy  $0.49  5/1/2020    M     100000      6/8/2019  6/8/2028  Common Stock  100000  $0  0  D   
Nonqualified Stock Option-right to buy  $0.565  5/1/2020    M     250000      11/8/2018  11/8/2028  Common Stock  250000  $0  0  D   
Nonqualified Stock Option-right to buy  $0.52  5/1/2020    M     66666      3/1/2020 (4) 6/18/2029  Common Stock  66666  $0  33334  D   
Nonqualified Stock Option-right to buy  $0.385  5/1/2020    M     750000      9/12/2019  9/12/2029  Common Stock  750000  $0  0  D   
Nonqualified Stock Option-right to buy  $0.39  5/1/2020    M     93750      4/7/2020  10/7/2029  Common Stock  93750  $0  0  D   
Nonqualified Stock Option-right to buy  $0.52  5/4/2020    M     8334      3/1/2020 (4) 6/18/2029  Common Stock  8334  $0  25000  D   

Explanation of Responses:
(1)  This amendment to Form 4 filed on May 5, 2020 amends the transaction code to "M" from the original and incorrect transaction code of "P." The transaction corresponds with the nonqualified option exercise on line 5 in Table II.
(2)  This transaction was executed in multiple trades at prices ranging from $3.16 to $3.37. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
(3)  The reporting person disclaims beneficial ownership in these securities and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reporting person for purposes of Section 16 or for any other purpose.
(4)  Option grant vests every four months beginning September 7, 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Kelly Scott A.
C/O CYTODYN INC.
1111 MAIN STREET, SUITE 660
VANCOUVER, WA 98660
X
Chairman & CMO

Signatures
Arian Colachis, Attorney-in-fact 5/15/2020
**Signature of Reporting Person Date
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more CytoDyn (QB) Charts.
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more CytoDyn (QB) Charts.